Ryan Maynard Net Worth & Insider Trades

Ryan Maynard - Director, Iovance Biotherapeutics, Inc

As of June 14, 2022

What is Ryan Maynard's Net Worth?

The current estimated net worth of Iovance Biotherapeutics, Inc's Director, Ryan Maynard, is estimated to be about $1.26M . Ryan Maynard owns about 7,500 units of Iovance Biotherapeutics, Inc common stock. In the last 4 years at Iovance Biotherapeutics, Inc, Ryan Maynard has sold an estimated value of $0 worth.

What is Ryan Maynard's Past Insider Trading?

Ryan Maynard's largest purchase order was 7,500 units , worth over $50.59K on June 2, 2022. In total, Ryan Maynard has made about 6 transactions over 4 years of their time at Iovance Biotherapeutics, Inc. Ryan Maynard usually trades in June, with the busiest year in 2022.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Ryan Maynard's' Mailing Address?

  • Mailing address is Rigel Pharmaceuticals, Inc. 1180 Veterans Blvd. South San Francisco CA 94080 CA

What are Iovance Biotherapeutics, Inc's Past Insider Trades?

Iovance Biotherapeutics, Inc's most recent insider trade came on June 2, 2022 by Merrill A McPeak who bought 20,000 units worth $136.4K . In the last 4 years, insiders at Iovance Biotherapeutics, Inc have sold an estimated value of $2.25M and bought an estimated value of $19.74M worth of shares. Insider trading is most common in June, with the busiest year in 2022. The most active traders at the company are Maria Fardis, President and CEO,  Merrill A McPeak, Director,  and Frederick G Vogt, Interim CEO & General Counsel .

IOVANCE BIOTHERAPEUTICS, INC. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1